Brazilian Manufacturer Called Out for Slew of Violations

Drug Industry Daily
A A
The FDA cited Brazilian OTC drugmaker Pietrobon for multiple violations including testing and equipment problems and poor recordkeeping.

To View This Article:

Login

Subscribe To Drug Industry Daily